MTND5P29

Across TCGA pan-cancer cohorts, MTND5P29 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTND5P29 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MTND5P29 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND5P29 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

UCS, LIHC, and HNSC are the cancer types where MTND5P29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.001	0.690	<.001	108	view →
LIHC	OS	Tertile	III,IV	0.051	0.738	<.001	42	view →
HNSC	OS	Tertile	II,III,IV	0.393	0.720	.014	39	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
PAAD	OS	Tertile	II,III,IV	0.353	0.562	.035	18	view →
ACC	DFS	Tertile	III,IV	0.048	0.457	.015	18	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
THYM	DFS	Tertile	All	0.092	0.871	<.001	9	view →
THCA	DFS	Tertile	IV	0.146	0.844	.007	9	view →
LAML	DFS	Median	All	0.281	0.467	.032	6	view →
SKCM	DFS	Tertile	All	0.954	0.714	.030	3	view →
ESCA	OS	Tertile	All	0.504	0.903	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MTND5P29–UCS (OS)

Open the UCS breakdown →